TWA
BDTX icon

TCI Wealth Advisors’s Black Diamond Therapeutics BDTX Stock Holding History

TCI Wealth Advisors’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-112
Closed -$1K – 2305
2021
Q3 		$1K Hold
112
– – ﹤0.01% 2227
2021
Q2 		$1K Hold
112
– – ﹤0.01% 2175
2021
Q1 		$3K Buy
+112
New +$3.02K ﹤0.01% 1491

Other funds holding BDTX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TCI Wealth Advisors's BDTX Position: Q4 2021 in Review

TCI Wealth Advisors sold out of Black Diamond Therapeutics (BDTX) in Q4 2021, closing a stake of 112 shares — an estimated $1K sold.

TCI Wealth Advisors first reported a position in BDTX in Q1 2021 and held it in 3 quarters. The position peaked at $3K in Q1 2021. 95 funds tracked by Wall St. Rank hold BDTX as of Q4 2021.

  • TCI Wealth Advisors reported no remaining Black Diamond Therapeutics position as of Q4 2021 after selling out during the quarter.
  • TCI Wealth Advisors sold 112 Black Diamond Therapeutics shares in Q4 2021, an estimated $1K.
  • TCI Wealth Advisors first reported a position in Black Diamond Therapeutics in Q1 2021 and held it in 3 quarters.
  • TCI Wealth Advisors's Black Diamond Therapeutics position peaked at $3K in Q1 2021.
  • 95 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q4 2021.

Based on TCI Wealth Advisors's 13F filing for Q4 2021, filed 24 Jan 2022.